OMV AG/ AT0000743059 /
5/23/2024 8:18:02 AM | Chg. -1.340 | Volume | Bid12:24:35 PM | Ask12:24:35 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
46.620EUR | -2.79% | 0 Turnover: 0.000 |
46.900Bid Size: 203 | 46.980Ask Size: 57 | 15.33 bill.EUR | 10.77% | 10.35 |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/2/2021
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...